BlackRock Fund Advisors - HEMISPHERX BIOPHARMA INC ownership

HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103. A total of 23 filers reported holding HEMISPHERX BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of HEMISPHERX BIOPHARMA INC
ValueSharesWeighting
Q2 2016$7,0000.0%57,294
+8.1%
0.00%
Q1 2016$7,000
+133.3%
53,006
+24.2%
0.00%
Q4 2015$3,00042,6880.00%
Other shareholders
HEMISPHERX BIOPHARMA INC shareholders Q4 2015
NameSharesValueWeighting ↓
Occidental Asset Management, LLC 190,000$184,0000.24%
TWO SIGMA SECURITIES, LLC 40,489$3,0000.00%
UBS Group AG 110,268$9,0000.00%
BLACKROCK ADVISORS LLC 68,726$6,0000.00%
CITY HOLDING CO 5,000$00.00%
WELLS FARGO & COMPANY/MN 4,396$00.00%
NORTHERN TRUST CORP 203,581$17,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 897,977$72,0000.00%
STATE STREET CORP 81,000$7,0000.00%
DEUTSCHE BANK AG\ 75,019$6,0000.00%
View complete list of HEMISPHERX BIOPHARMA INC shareholders